Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Duensing

Showing results (121-130 of 139) with videos related to

Pageof 14
Sort By:
European Urology Focus|March 18, 2019
Standardized Magnetic Resonance Imaging Reporting Using the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation Criteria and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion with Transperineal Saturation Biopsy to Select Men on Active SurveillanceSvenja Dieffenbacher, Joanne Nyarangi-Dix, Francesco Giganti, et al.
Plos One|August 23, 2012
Mitochondrial respiration--an important therapeutic target in melanomaMichelle Barbi de Moura, Garret Vincent, Shelley L Fayewicz, et al.
Urologic Oncology|July 18, 2020
Rearranged ERG confers robustness to prostate cancer cells by subverting the function of p53Adam Kaczorowski, Yanis Tolstov, Michael Falkenstein, et al.
European Urology|April 13, 2017
Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for Advanced Risk Modeling of Prostate Cancer-Patient-tailored Risk Stratification Can Reduce Unnecessary BiopsiesJan Philipp Radtke, Manuel Wiesenfarth, Claudia Kesch, et al.
Cancer Immunology, Immunotherapy : CII|September 25, 2019
The BRCA2 mutation status shapes the immune phenotype of prostate cancerMaximilian Jenzer, Peter Keß, Cathleen Nientiedt, et al.
Urologic Oncology|December 5, 2017
Overexpression of nuclear AR-V7 protein in primary prostate cancer is an independent negative prognostic marker in men with high-risk disease receiving adjuvant therapyXin Chen, Christof Bernemann, Yuri Tolkach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2016
Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate CancerJohannes Brägelmann, Niklas Klümper, Anne Offermann, et al.
European Urology|January 27, 2016
Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy SpecimenJan P Radtke, Constantin Schwab, Maya B Wolf, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2017
Intraindividual Comparison of <sup>18</sup>F-PSMA-1007 PET/CT, Multiparametric MRI, and Radical Prostatectomy Specimens in Patients with Primary Prostate Cancer: A Retrospective, Proof-of-Concept StudyClaudia Kesch, Maria Vinsensia, Jan P Radtke, et al.
Carcinogenesis|September 6, 2021
Analysis of tripartite motif (TRIM) family gene expression in prostate cancer bone metastasesAnne Offermann, Duan Kang, Christian Watermann, et al.
Pageof 14

Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
European Urology Focus|March 18, 2019
Standardized Magnetic Resonance Imaging Reporting Using the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation Criteria and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion with Transperineal Saturation Biopsy to Select Men on Active SurveillanceSvenja Dieffenbacher, Joanne Nyarangi-Dix, Francesco Giganti, et al.
Plos One|August 23, 2012
Mitochondrial respiration--an important therapeutic target in melanomaMichelle Barbi de Moura, Garret Vincent, Shelley L Fayewicz, et al.
Urologic Oncology|July 18, 2020
Rearranged ERG confers robustness to prostate cancer cells by subverting the function of p53Adam Kaczorowski, Yanis Tolstov, Michael Falkenstein, et al.
European Urology|April 13, 2017
Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for Advanced Risk Modeling of Prostate Cancer-Patient-tailored Risk Stratification Can Reduce Unnecessary BiopsiesJan Philipp Radtke, Manuel Wiesenfarth, Claudia Kesch, et al.
Cancer Immunology, Immunotherapy : CII|September 25, 2019
The BRCA2 mutation status shapes the immune phenotype of prostate cancerMaximilian Jenzer, Peter Keß, Cathleen Nientiedt, et al.
Urologic Oncology|December 5, 2017
Overexpression of nuclear AR-V7 protein in primary prostate cancer is an independent negative prognostic marker in men with high-risk disease receiving adjuvant therapyXin Chen, Christof Bernemann, Yuri Tolkach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2016
Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate CancerJohannes Brägelmann, Niklas Klümper, Anne Offermann, et al.
European Urology|January 27, 2016
Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy SpecimenJan P Radtke, Constantin Schwab, Maya B Wolf, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2017
Intraindividual Comparison of <sup>18</sup>F-PSMA-1007 PET/CT, Multiparametric MRI, and Radical Prostatectomy Specimens in Patients with Primary Prostate Cancer: A Retrospective, Proof-of-Concept StudyClaudia Kesch, Maria Vinsensia, Jan P Radtke, et al.
Carcinogenesis|September 6, 2021
Analysis of tripartite motif (TRIM) family gene expression in prostate cancer bone metastasesAnne Offermann, Duan Kang, Christian Watermann, et al.
Pageof 14